A panelist discusses how tumor heterogeneity (both spatial and temporal) affects molecular testing reliability in ovarian ...

Currently, blood-based screening is mostly appropriate for high-risk groups, such as: Prostate cancer: Men over 50 may ...

Researchers in Japan have developed a predictive model that could improve treatment decisions for advanced pancreatic cancer ...

Brain tumors strike over 25,000 Americans annually with often subtle warning signs. Learn crucial facts about detection, ...

Researchers in Japan have developed a predictive model that could improve treatment decisions for advanced pancreatic cancer ...

A 69 year old female patient with cancer in the head (widest part) of the pancreas spreading to a major abdominal artery ...

Tumor size, multiplicity ... to the extrapolation of new means for detection of recurrent bladder cancer. Biological markers for bladder cancer could be used alone or as an adjunct to urine ...

The Tumor Marker Gene Model (TMGM) is a diagnostic tool to determine if patients with pancreatic cancer are suited for post-treatment surgery. It determines how a patient's DNA affects their tumor ...

Scientists from the Moffitt Cancer Center say they now have a better understanding why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their ...

Circulating tumor cells comprise a heterogeneous ... of ERBB2 status in CTCs offer promise of a breast cancer specific marker for improved management of metastatic disease. [148] The ability ...